Skip to content

An Interventional study with LM Potency on patients with grade 1 Hypertension

Efficacy Of Homoeopathic Medicines Using LM Potency in Management Of Essential Hypertension(Grade 1) in Patients having Body Mass Index 25-35 - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066570
Enrollment
40
Registered
2024-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Medicine In LM potency: Potency LM Potency Dose as per the criteria of LM Potency Medicine will dispensed as per the criteria of LM potency Frequency as per need of case route of admini

Sponsors

DrArfana Chauhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants must have a confirmed diagnosis of essential hypertension as per established medical criteria Participants with baseline Systolic Blood Pressure more than 120 to 159 and Diastolic Blood Pressure more than 80 to 99 who are not on any anti hypertensive medicines Participants with a body mass index of 25 to 35 Participants willing to provide informed consent to participate in the study and also who can fill up the Questionnaire

Exclusion criteria

Exclusion criteria: Patients who are suffering from secondary Hypertension of known aetiology such as renal disease pheochromocytoma or Cushing’s syndrome known diabetics, history of myocardial infarction severe coronary artery disease or clinically significant heart failure or valvular defect or known cases of cardiac diseases any systemic illness consumptive disease autoimmune disease cancer hepatic disease renal disease Patients receiving any drugs known to affect Blood Pressure or medical treatments that can influence the Blood Pressure having a history of alcohol or drug abuse Women who are taking contraceptive pills pregnancy and lactating mother Patients having class 2 and class 3 obesity

Design outcomes

Primary

MeasureTime frame
changes in the blood pressure both systolic and diastolicTimepoint: data will be assessed from baseline 2 4 6 8 months and changes in the blood pressure will be assessed

Secondary

MeasureTime frame
changes in the Minichal Questinnorie scoreTimepoint: from baseline to at the end of treatment

Countries

India

Contacts

Public ContactDrArfana Chauhan

Smt A J Savla Homoepathic Medical college and Research Institute

dranandjvb@gmail.com9979885148

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026